EIKON
DEAD

Serial Number

90690436

Owner

EIKON THERAPEUTICS, INC.

Attorney

Ilene B. Tannen

Filing Date

May 4, 2021

Add to watchlist:

No watchlists yet
View on USPTO

EIKON Trademark

Serial Number: 90690436

EIKON is a trademark filed by EIKON THERAPEUTICS, INC. on May 4, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

EIKON THERAPEUTICS, INC.

230 Harriet Tubman Way
Millbrae, CA 94030

Entity Type: 03

Trademark Details

Filing Date

May 4, 2021

Registration Date

Not Registered

Published for Opposition

June 7, 2022

Goods & Services

Pharmaceutical preparations comprising small molecules, biologics being biopharmaceuticals and biologically active substances for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders, and vaccines; pharmaceutical products, preparations and agents for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; biopharmaceuticals for the prevention and treatment of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; therapeutic products, preparations and agents for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; diagnostic products, preparations and agents for medicinal purposes

Providing a website featuring technology that allows users to conduct drug discovery and development; Providing a website featuring technology that allows users to track and measure movement of proteins in living cells

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 17, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 17, 2025 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 25, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 25, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 25, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 25, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 25, 2025 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 27, 2025 EXRA
SOU EXTENSION 5 GRANTED
Mar 26, 2025 EX5G
SOU EXTENSION 5 FILED
Jan 30, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 30, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 26, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jul 26, 2024 EX4G
SOU EXTENSION 4 FILED
Jul 26, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 26, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 23, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jan 19, 2024 EX3G
SOU EXTENSION 3 FILED
Jan 19, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 19, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 25, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jul 21, 2023 EX2G
SOU EXTENSION 2 FILED
Jul 21, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 21, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 4, 2023 EXRA
SOU EXTENSION 1 GRANTED
Feb 2, 2023 EX1G
SOU EXTENSION 1 FILED
Feb 2, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 2, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 2, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 7, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 7, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 18, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 4, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
May 4, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 4, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 4, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 4, 2022 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 4, 2022 ZZZX
WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
May 4, 2022 PBMR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 2, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
May 2, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 2, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 2, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 2, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 6, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 6, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 6, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 5, 2022 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 13, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 13, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 13, 2021 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 6, 2021 NWOS
NEW APPLICATION ENTERED
May 7, 2021 NWAP